| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment | Phase III | rekrutiert |
| A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany | — | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severe | Phase III | rekrutiert |
| A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin | — | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulc | Phase II | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide | Phase I | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participan | Phase III | rekrutiert |
| A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria | Phase II | rekrutiert |
| A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticos | Phase III | rekrutiert |
| An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psor | — | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positi | ohne Phasenangabe | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| Device Global Registry for the IlluminOss Bone Stabilization System | — | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| Early Catheter-directed Treatment of High Risk Pulmonary Embolism | ohne Phasenangabe | rekrutiert |
| Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) | Phase III | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer | ohne Phasenangabe | rekrutiert |
| Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study | — | rekrutiert |
| Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surr | ohne Phasenangabe | rekrutiert |
| Investigation of the Effect of Lipikar Baume AP+M | ohne Phasenangabe | rekrutiert |
| Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Kerato | — | rekrutiert |
| MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | Phase III | rekrutiert |
| Marker - Adjusted Therapy Comparing Adjuvant Elacestrant With Standard Endocrine Treatment in Ge | Phase III | rekrutiert |
| NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine | — | rekrutiert |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-ne | Phase III | rekrutiert |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HE | Phase II | rekrutiert |
| NeoRad Breast Cancer Study | Phase III | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure ( | — | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negativ | Phase III | rekrutiert |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation | ohne Phasenangabe | rekrutiert |
| RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | ohne Phasenangabe | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Real World Data Collection on the INSPIRIS RESILIA Aortic Valve | — | rekrutiert |
| Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wi | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearran | Phase III | rekrutiert |
| Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for P | Phase III | rekrutiert |
| Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Inve | Phase II / Phase III | rekrutiert |
| Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Bre | Phase I / Phase II | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term P | — | rekrutiert |
| Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With | Phase II | rekrutiert |
| The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases | — | rekrutiert |
| TrueLok Elevate PMCF Study | — | rekrutiert |